Esperovax
Chemicals & Related Products · Michigan, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
46701 Commerce Center Dr, Plymouth, Mich...Phone Number
(248) 667-1845Website
www.esperovax.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Esperovax
Esperovax is a biotechnology company based in Plymouth, MI, that specializes in developing targeted oral mRNA vaccines and biologics. Their innovative platform aims to provide safer, more cost-effective alternatives to traditional injectable vaccines, with a focus on large-scale production and distribution of shelf-stable products. The company aspires to lead in the field of oral vaccinations for various deadly diseases, making significant contributions to global health. Their mission emphasizes the delivery of rapid, painless, and inexpensive biological medicines to prevent and treat infections in both humans and animals.Explore more
Popular SearchesEsperovax LLCEsperovax IncEsperovaxSIC Code 28,283NAICS Code 32,325Show moreEsperovax Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Esperovax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Esperovax, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Esperovax
Earning: See what the market has to say on Esperovax recently announced quarterly report
Funding: Get notified immidiatlly once Esperovax has new funding data
Click to see if Esperovax had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Esperovax is spiking on competitors!
Product Launch: Get notified when Esperovax launches new products
Check if Esperovax has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Esperovax
Find 2 more new buyers
Compare Similar Companies to Esperovax
Compare insights from companies similar to Esperovax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Esperovax is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Esperovax is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Esperovax.
Esperovax Tech Stack
A closer look at the technologies used by Esperovax
See more technologies
Esperovax News & Media
Esperovax Awarded $1M for Development of an Oral COVID-19 RNA Vaccine under the HHS Project NextGen Initiative
PLYMOUTH, Mich., Oct. 3, 2023 /PRNewswire/ -- Esperovax, a U.S.-based preclinical biopharmaceutical company and a BLUE KNIGHT™ resident company, is receiving an award for $ 1 M to further develop a yeast-based oral COVID-19 RNA vaccine candidate as part of the BLUE KNIGHT™ QuickFire...Esperovax Appoints Dr. Robin Robinson as President and CEO
PLYMOUTH, Mich., May 1, 2023 /PRNewswire/ -- Esperovax, Inc. a leading oral RNA vaccine and therapeutic technology company specializing in oral mRNA-based medicines, announced today the appointment of Dr. Robin Robinson as President and Chief Executive Officer (CEO). Dr. Robinson will...Esperovax and Ginkgo Bioworks Announce Partnership to Develop Circular RNA-based Therapeutics
Initial focus of partnership will aim to develop cancer therapeutics PLYMOUTH, Mich. and BOSTON, Jan. 5, 2023 /PRNewswire/ -- Esperovax, an innovative developer of oral mRNA biologics, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and...ESPEROVAX SIGNS EXCLUSIVE LICENSING AGREEMENT WITH THE UNIVERSITY OF MICHIGAN FOR A NOVEL MANUFACTURING TECHNOLOGY FOR THE PRODUCTION OF VACCINES AND THERAPEUTICS
Initiative to enable continuous oral vaccine and therapeutics manufacturing for diseases worldwide ANN ARBOR, Mich., Nov. 30, 2022 /PRNewswire/ -- Esperovax, a leading developer of oral vaccines, today announced it has signed a new, exclusive licensing agreement with Innovation Partners...
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Esperovax
Sign Up For FreeTo access detailed company insights
Esperovax is a biotechnology company based in Plymouth, MI, that specializes in developing targeted oral mRNA vaccines and biologics. Their innovative platform aims to provide safer, more cost-effective alternatives to traditional injectable vaccines, with a focus on large-scale production and distribution of shelf-stable products. The company aspi... Read More
